THURSDAY, Nov. 21, 2024 (HealthDay News) — Think of it as collateral damage: Millions of Americans say they have been harmed by a loved one’s drug or alcohol use. One in 3 adults who responded to a new nationwide survey said they had suffered “secondhand harm” from another person’s drinking.Continue Reading
TUESDAY, Nov. 19, 2024 (HealthDay News) — Alcohol-related deaths have surged in the United States, nearly doubling over 20 years, and a growing number of victims are women, a new study warns. “Our study found significant gender differences in alcohol-related [death rates],” said senior author Yiota Kitsantas, head of populationContinue Reading
FRIDAY, Nov. 15, 2024 (HealthDay News) — There have been a slew of studies recently supporting the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to curb problem drinking. Now, a new study out of Britain adds to that growing pileContinue Reading
WEDNESDAY, Nov. 13, 2024 (HealthDay News) — The blockbuster GLP-1 drug semaglutide (Ozempic, Wegovy) could curb drinking for people battling alcohol use disorder, helping them to avoid crises that require hospitalization, new research shows. Numerous studies had already hinted that semaglutide might act on appetite centers in the brain toContinue Reading
WEDNESDAY, Nov. 13, 2024 (HealthDay News) — Obesity, alcohol use and other factors are driving up rates of fatty liver disease among American adults, new research warns. By 2018, federal data showed that 42% of adults had some form of fatty liver disease — higher than prior estimates, according toContinue Reading
TUESDAY, Nov. 12, 2024 (HealthDay News) — Even as the pressures of the pandemic began to ebb, Americans’ growing dependence on alcohol did not, a troubling new study shows. Two years into the globe-altering health crisis, the percentage of Americans who consumed alcohol — which had already spiked between 2018Continue Reading
-690x550.jpg)
THURSDAY, Oct. 17, 2024 (HealthDay News) — Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid addiction, a new study finds. People taking this class of drugs, called glucagon-like peptide-1 receptor agonists (GLP-1), have a 50% lower rate of drunkenness thanContinue Reading
MONDAY, Oct. 14, 2024 (HealthDay News) — Binge drinking at a party or club could feel great when the music’s beating, but it’s your heart beat that might pay the price. Researchers in Germany found that 1 in every 20 young Munich revelers developed “clinically relevant arrhythmias” as they gotContinue Reading
THURSDAY, Aug. 15, 2024 (HealthDay News) — Regular bedtimes won’t just help your child be alert for a busy school day; they might also help keep them from abusing drugs or alcohol as a teen, new research suggests. Youth who’d had early bedtimes in childhood and adolescence were significantly lessContinue Reading
TUESDAY, Aug. 13, 2024 (HealthDay News) — New research confirms that alcohol is not your friend as you age: Even light drinking was linked to an increase in cancer deaths among older adults, with the raised risk most pronounced in those who had other health problems or lived in low-income areas. TheContinue Reading